Journal Article

Acupuncture for irritable bowel syndrome: study protocol for a multicenter randomized controlled trial

Wu, Xiao-liang, Ju, Lu, Qin, Shan, Pei, Li-xia, Lu, Gao, Xu, Wan-li, Geng, Hao, Zhou, Jun-ling, Chen, Lu, Chen, Hao, Guo, Jing, Sun, Jian-hua, Yang, Eun Mee

2018

Overview

Background Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by abdominal pain and change of bowel habit without organic disease. A global perspective given by the World Gastroenterology Organization (WGO) points out that IBS can impact the quality of an individual’s daily life, cause socioeconomic problems and potentially impair the patient-physician relationship. It remains a problem to treat IBS due to the complicated pathophysiology. Acupuncture is an alternative therapy recommended for IBS. The aim of this study is to investigate the efficacy and safety of acupuncture therapy for patients with IBS. We also want to explore the correlation between IBS-gene subtypes and acupuncture effect. Methods/design A multicenter randomized controlled trial will be performed in seven hospitals. Six hundred participants will be stratified into two strata (IBS-C or IBS-D). Then, patients within each stratum will be divided into an experimental group and a control group randomly. The experimental group is treated with acupuncture while the control group is treated with Western medicine. All the patients will receive a 6-week treatment and a 3-month follow-up. The primary outcome is the IBS-Symptom Severity Score (IBS-SSS), the secondary outcome is the score of the IBS-Quality of Life (IBS-QoL).The correlation between IBS-gene subtypes and acupuncture effect will be detected based on polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Outcome measures (including primary and secondary outcome measures) are collected at baseline,1 week, 2 weeks, 4 weeks, and 6 weeks of the intervention, and 12 weeks after the intervention. Discussion This is a multicenter randomized controlled trial for IBS in China. It may clarify the efficacy of acupuncture as an alternative therapy for IBS. This is the first time ever that the potential mechanism of IBS based on genomics has been investigated. Trial registration Chinese Clinical Trials Register, ID: ChiCTR-IOR-15006259 . First registered on 14 April 2015.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Abdominal Pain - diagnosis / Abdominal Pain - genetics / Abdominal Pain - physiopathology / Abdominal Pain - therapy / Acupuncture / Acupuncture effect / Acupuncture Therapy / Adolescent / Adult / Aged / Analysis / Biomedicine / Care and treatment / China / Clinical trials / Diagnosis / Disease / Female / Genetic Predisposition to Disease / Health Sciences / Hospitals / Humans / Irritable bowel syndrome / Irritable Bowel Syndrome - diagnosis / Irritable Bowel Syndrome - genetics / Irritable Bowel Syndrome - physiopathology / Irritable Bowel Syndrome - therapy / Male / Medicine / Medicine & Public Health / Middle Aged / Multicenter Studies as Topic / Pain Measurement / Phenotype / Polymorphism / Protocol / Quality of Life / Randomized controlled trials / Randomized Controlled Trials as Topic / Safety and security measures / Serotonin / Severity of Illness Index / Statistics for Life Sciences / Study Protocol / Time Factors / Traditional Chinese medicine / Treatment Outcome / Young Adult